Biotechnology Research Reports

  The global   Legionella Testing Market   size is expected to value at USD 352.6 million by 2025. The market is subject to witness a substantial growth due to the growing prevalence of legionella-based disorders coupled with increasing awareness among general population in regards to their preventive management. Legionella can lead to legionellosis, which is a respiratory disorder, also known as a pneumonia. Treatment of legionellosis involves intensive care and hospitalization, and comes under the public health concerns. As per recent reports, as many as 4,568 cases were registered of Legionnaires’ disease in the last one years. Globally, the legionella testing industry is predicted to grow at CAGR of 8.4% in the forecast period, providing numerous opportunities for market players to invest for research and development in the market. Legionella bacteria are particularly found in the hot water conditions. Numerous industries with high requirement for water are likely susceptible towar

  The global Bone Morphogenetic Protein Market is set to witness a higher CAGR during the forecast period. Molecular cloning of bone morphogenetic proteins validate their family of differentiation factors and each capable of stimulating the development of new bone tissue once implanted. Morphogenetic based products are a revolution for several therapies in orthopaedic practices. Technically, bone matrix comprises a diversity of protein components entailing an array of growth and differentiation factors. Developments in the biochemical techniques and inception of biotechnology certainly allows purification followed by molecular cloning Driving factors for bone morphogenetic proteins market include rise in number of patients with spinal injuries along with an increase in surgical rate. Rise in spinal fusion, small bone surgeries and trauma are likely to propel the market growth in the forecast period. Low back pain is one of the main reasons occurring due to lifestyle disorders resulting